DUALITY ADVISERS, LP - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 1 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DUALITY ADVISERS, LP ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$2,416,000
+356.7%
119,842
+399.4%
0.18%
+374.4%
Q4 2020$529,00023,9950.04%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 8,930,237$85,373,00050.34%
RTW INVESTMENTS, LP 5,029,462$48,082,0004.58%
EcoR1 Capital, LLC 4,764,447$45,548,0004.57%
RA Capital Management 3,933,489$37,604,0002.88%
Cormorant Asset Management, LP 3,600,954$34,425,0002.57%
Omega Fund Management, LLC 223,457$2,136,0002.10%
Ghost Tree Capital, LLC 950,000$9,082,0001.84%
EMORY UNIVERSITY 246,411$2,356,0001.68%
Trustees of Princeton University 114,286$1,093,0001.63%
BRIDGER MANAGEMENT, LLC 1,226,820$11,728,0000.71%
View complete list of DICERNA PHARMACEUTICALS INC shareholders